Medindia LOGIN REGISTER
Medindia

Latest Publications and Research on Top Foods to Lower Triglycerides


Int J Surg Case Rep      

An obese patient with acute cholecystitis, nonalcoholic steatohepatitis and cirrhosis: A case report.

Zuiki T, Ohki J, Horiuchi T, Lefor AK, Shirakata F, Hirota Y, Hirota N

Laparoscopic cholecystectomy for patients with acute cholecystitis and liver cirrhosis is associated with increased risk. We present an obese patient ... Read More

Source: PubMed
J. Nutr. Biochem.      

Maize extract rich in ferulic acid and anthocyanins prevents high-fat-induced obesity in mice by modulating SIRT1, AMPK and IL-6 associated metabolic and inflammatory pathways.

Luna-Vital D, Luzardo-Ocampo I, Cuellar-Nuñez ML, Loarca-Piña G, Gonzalez de Mejia E

The aim was to compare the antiobesity efficacy of different concentrations of a phenolic-rich water extract from purple maize pericarp (PPE) in a mur ... Read More

Source: PubMed
J. Diabetes Complicat.   2019 Dec 30   

Overweight and obese children with optimal control in the T1D Exchange Registry: How are they different from lean children with optimal control?

Flokas ME, Zeymo A, Mete M, Anhalt H, Rother KI, Gourgari E

Increased adiposity is a risk factor for suboptimal diabetes control and cardiovascular disease (CVD) complications. Our goal was to identify modifiab ... Read More

Source: PubMed
Diabetes Res. Clin. Pract.   2020 Jan 29   

Knockout of Farnesoid X receptor Aggravates Process of Diabetic Cardiomyopathy.

Qiang S, Tao L, Zhou J, Wang Q, Wang K, Lu M, Wang W, Han L, Xue S, Chen Y, Zh H, Liu Z, Zhang Y

Previous studies have shown that FXR is involved in glycolipid metabolism, tissue inflammation and regeneration in organs such as the liver, intestine ... Read More

Source: PubMed
Biochem. Biophys. Res. Commun.   2020 Jan 28   

Pemafibrate, a selective PPARa modulator, and fenofibrate suppress microglial activation through distinct PPARa and SIRT1-dependent pathways.

Ogawa K, Yagi T, Guo T, Takeda K, Ohguchi H, Koyama H, Aotani D, Imaeda K, Kataoka H, Tanaka T

Pemafibrate, a selective peroxisome proliferator-activated receptor (PPAR) a modulator, is a new drug that specifically modulates PPARa conformation a ... Read More

Source: PubMed
Advertisement